Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria

NCT02010242 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus With Diabetic Nephropathy

Interventions

DRUG: GKT137831
DRUG: Placebo

Sponsor

Calliditas Therapeutics AB